HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrzej W Lipkowski Selected Research

biphalin

11/2016Different blood pressure responses to opioids in 3 rat hypertension models: role of the baseline status of sympathetic and renin-angiotensin systems.
6/2016Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
2/2016An antihypertensive opioid: Biphalin, a synthetic non-addictive enkephalin analog decreases blood pressure in spontaneously hypertensive rats.
2/2016Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI).
2/2016Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.
10/2014Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases.
1/2011Delta opioid receptors contribute to the cardiorespiratory effects of biphalin in anesthetized rats.
8/2010A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro.
1/2009Respiratory and cardiovascular effects of biphalin in anaesthetized rats.
3/2008Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrzej W Lipkowski Research Topics

Disease

11Pain (Aches)
10/2016 - 03/2008
7Neoplasms (Cancer)
06/2016 - 03/2008
5Melanoma (Melanoma, Malignant)
01/2019 - 12/2012
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2015 - 01/2003
4Neuralgia (Stump Neuralgia)
01/2016 - 03/2004
3Hypertension (High Blood Pressure)
11/2016 - 10/2014
3Chronic Pain
10/2016 - 03/2008
3Cancer Pain
06/2016 - 01/2012
3Alcoholism (Alcohol Abuse)
07/2014 - 01/2009
2Infections
11/2018 - 03/2008
2Hypotension (Low Blood Pressure)
02/2017 - 01/2011
2Wounds and Injuries (Trauma)
01/2017 - 02/2016
2Hypersensitivity (Allergy)
10/2016 - 12/2012
2Respiratory Insufficiency (Respiratory Failure)
01/2016 - 06/2007
2Apnea
01/2011 - 06/2007
2Bradycardia
01/2011 - 01/2009
1Cicatrix (Scar)
01/2017
1Contact Dermatitis (Eczema, Contact)
10/2016
1Inflammation (Inflammations)
10/2016
1Acute Pain
10/2016
1Skin Neoplasms (Skin Cancer)
06/2016
1Hypothermia
06/2016
1Diarrhea
02/2016
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
02/2016
1Brain Concussion (Cerebral Concussion)
02/2016
1Opioid-Related Disorders (Opiate Addiction)
02/2016
1Demyelinating Diseases (Demyelinating Disease)
01/2015
1Abdominal Pain (Pain, Abdominal)
10/2014
1Colitis
10/2014
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2014
1Lymphoma (Lymphomas)
01/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2014
1Carcinogenesis
01/2012
1Hyperalgesia
01/2012
1Brain Hypoxia (Cerebral Hypoxia)
11/2011
1Ischemia
11/2011
1Nociceptive Pain
01/2011
1Constipation
12/2010

Drug/Important Bio-Agent (IBA)

16Opioid Analgesics (Opioids)IBA
11/2016 - 03/2004
11biphalinIBA
11/2016 - 07/2005
10Peptides (Polypeptides)IBA
01/2019 - 03/2004
9Opioid Receptors (Opioid Receptor)IBA
02/2017 - 08/2010
9Analgesics (Analgesic Drugs)IBA
10/2016 - 12/2010
6Morphine (MS Contin)FDA LinkGeneric
06/2016 - 08/2010
4NeurotensinIBA
02/2017 - 09/2013
3EnkephalinsIBA
11/2016 - 03/2008
3Opioid Peptides (Opioid Peptide)IBA
06/2016 - 01/2011
3Pharmaceutical PreparationsIBA
06/2016 - 07/2005
3LigandsIBA
01/2016 - 01/2013
3AntigensIBA
05/2015 - 12/2012
2Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2009
2Naltrexone (ReVia)FDA LinkGeneric
02/2016 - 01/2012
2MutagensIBA
09/2013 - 01/2012
2SolutionsIBA
08/2010 - 07/2005
2mu Opioid Receptors (mu Opioid Receptor)IBA
08/2010 - 05/2005
14-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA
01/2019
1Sodium Glutamate (Accent)IBA
01/2019
1AntioxidantsIBA
01/2019
1Dendrimers (Dendrons)IBA
01/2019
1Glutamic Acid (Glutamate)FDA Link
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Amino AcidsFDA Link
11/2018
1Antimicrobial PeptidesIBA
11/2018
1adenosine 5'-phosphorothioate (AMP-S)IBA
11/2018
1Keratins (Keratin)IBA
01/2017
1ReninIBA
11/2016
1SaltsIBA
11/2016
1AngiotensinsIBA
11/2016
1endomorphin 2IBA
10/2016
1neurotensin (8-13)IBA
10/2016
1DinitrofluorobenzeneIBA
10/2016
1HaptensIBA
10/2016
1Narcotic Antagonists (Opioid Antagonists)IBA
06/2016
1N-methylnaloxoneIBA
06/2016
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2016
1Castor Oil (Oil, Castor)IBA
02/2016
1Naloxone (Narcan)FDA LinkGeneric
02/2016
1Antihypertensive Agents (Antihypertensives)IBA
02/2016
1NociceptinIBA
01/2016
1PeptidomimeticsIBA
12/2015
1Losartan (Cozaar)FDA LinkGeneric
10/2014
1Norepinephrine (Noradrenaline)FDA LinkGeneric
10/2014
1SodiumIBA
10/2014
1PD 123319IBA
10/2014
1Ethanol (Ethyl Alcohol)IBA
07/2014
1Neurotensin Receptors (Neurotensin Receptor)IBA
09/2013
1Fentanyl (Sublimaze)FDA LinkGeneric
01/2013
1Opiate AlkaloidsIBA
01/2013
1VaccinesIBA
12/2012
1CarcinogensIBA
01/2012
1Therapeutic UsesIBA
01/2011
1naltrindoleIBA
01/2011

Therapy/Procedure

6Therapeutics
10/2016 - 03/2008
5Analgesia
06/2016 - 07/2005
2Oral Administration
05/2015 - 01/2015
2Vagotomy
01/2009 - 06/2007
1Intravenous Administration
02/2017
1Intradermal Injections
05/2015
1Lasers (Laser)
10/2014
1Lymph Node Excision (Lymph Node Dissection)
12/2012